Xcorporeal Net Income Applicable To Common Shares from 2010 to 2026
| XCRP Stock | USD 0.0001 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -3.8 K | Current Value -4 K | Quarterly Volatility 7.7 K |
Check Xcorporeal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xcorporeal's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 4.4 K or Total Revenue of 144, as well as many indicators such as Price To Sales Ratio of 15.8, Dividend Yield of 0.088 or Days Sales Outstanding of 1.1 K. Xcorporeal financial statements analysis is a perfect complement when working with Xcorporeal Valuation or Volatility modules.
Xcorporeal | Net Income Applicable To Common Shares | Build AI portfolio with Xcorporeal Stock |
Latest Xcorporeal's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Xcorporeal over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Xcorporeal's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xcorporeal's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Xcorporeal Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (6,051) | |
| Coefficient Of Variation | (126.50) | |
| Mean Deviation | 3,494 | |
| Median | (4,236) | |
| Standard Deviation | 7,655 | |
| Sample Variance | 58.6M | |
| Range | 31.9K | |
| R-Value | 0.42 | |
| Mean Square Error | 51.7M | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | 629.82 | |
| Total Sum of Squares | 937.5M |
Xcorporeal Net Income Applicable To Common Shares History
About Xcorporeal Financial Statements
Xcorporeal shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Xcorporeal investors may analyze each financial statement separately, they are all interrelated. The changes in Xcorporeal's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xcorporeal's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -3.8 K | -4 K |
Additional Tools for Xcorporeal Stock Analysis
When running Xcorporeal's price analysis, check to measure Xcorporeal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xcorporeal is operating at the current time. Most of Xcorporeal's value examination focuses on studying past and present price action to predict the probability of Xcorporeal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xcorporeal's price. Additionally, you may evaluate how the addition of Xcorporeal to your portfolios can decrease your overall portfolio volatility.